Tobacco (Nicotine) Use Disorder is a substance use disorder characterized by a problematic pattern of tobacco (nicotine) use leading to clinically significant impairment or distress. Like with all substance use disorders, there is a complex interplay between biological, social, psychological, and cultural factors.
A problematic pattern of tobacco use leading to clinically significant impairment or distress, as manifested by at least 2
of the following, occurring within a 12
-month period:
Criteria A and B
of the criteria set for tobacco withdrawal).Specify if:
3
months but for less than 12
months (with the exception that Criterion A4
, “Craving, or a strong desire or urge to use tobacco,” may be met).12
months or longer (with the exception that Criterion A4
, “Craving, or a strong desire or urge to use tobacco,” may be met).Specify if:
Specify if:
2
to 3
symptoms4
to 5
symptoms6
+ symptomsAmount smoked | Patch Dose | Gum Dose |
---|---|---|
<5 cigarettes per day, or if unable to tolerate NRT | 7mg daily | • Adjunct to patch: 2mg piece q1-2h PRN (max 15 pieces) • Monotherapy: 2mg piece q1-2h PRN (max 20 pieces) |
5-10 cigarettes daily | 14mg daily | Same as above |
10-25 cigarettes daily | 21mg daily | • Adjunct to patch: 2mg piece q1-2h PRN (max 15 pieces) • Monotherapy: 4mg (FOUR) piece q1-2h PRN (max 20 pieces) |
>25 cigarettes daily | 21mg x 2 daily | Same as above |
Guideline | Location | Year | Website | |
---|---|---|---|---|
Canadian Medical Association Journal (CMAJ) | Canada | 2016 | - | Link |
CAN-ADAPTT Guideline for Smoking Cessation | Canada | 2011 | - | Link |
U.S. Public Health Service | US | 2008 | - | Link |
Agency for Healthcare Research and Quality (AHRQ) | US | 2008 | - | Link |
National Institute for Health and Care Excellence (NICE) | UK | 2018 | - | Link |